Dr. Taylor-Cousar is a tenured professor of adult and pediatric pulmonary medicine at National Jewish Health (NJH), where she serves as the Medical Director of Clinical Research Services, President of the Medical Staff, and is co-director of the Adult Cystic Fibrosis (CF) Program and Director of the CF Therapeutics Development Network (TDN) center. She received her undergraduate degree in human biology from Stanford University, and completed her doctorate in medicine, combined residency in internal medicine and pediatrics, and her combined fellowship in adult and pediatric pulmonary medicine at Duke University. She obtained her Master of Clinical Science from the University of Colorado.

Dr. Taylor-Cousar’s expertise is clinical trial design and conduct; she has been national/global primary investigator on multiple CF TDN pharmaceutical trials. Her investigator-initiated research focuses on the development and evaluation of novel therapies for the treatment of CF, and the long-term impacts of these therapeutics on health outcomes in people with CF; she is currently co-leading the 41-site prospective Maternal and Fetal Outcomes in the Era of Modulators (MAYFLOWERS) study. She has published more than 140 manuscripts as well as a book and multiple book chapters. Additionally, she serves on a number of national scientific advisory committees for Emily’s Entourage, the Cystic Fibrosis Foundation, American Thoracic Society and the National Institutes of Health. She is an Associate Editor for the Journal of Cystic Fibrosis and a member of the International Advisory Board for the Lancet Respiratory Medicine.